{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:31:05Z","timestamp":1786991465992,"version":"build-2736575974"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.japh.2022.09.018","type":"journal-article","created":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T11:45:58Z","timestamp":1664365558000},"page":"295-300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["A pilot study assessing client understanding and use of fentanyl test strips for harm reduction"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3881-4328","authenticated-orcid":false,"given":"Aleeya A.","family":"Barrolle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3123-9965","authenticated-orcid":false,"given":"Kelly N.","family":"Gable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3055-6301","authenticated-orcid":false,"given":"Nathaniel","family":"Dell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"50","key":"10.1016\/j.japh.2022.09.018_bib1","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.15585\/mmwr.mm7050e3","article-title":"Trends in and characteristics of drug overdose deaths involving illicitly manufactured fentanyls - United States, 2019\u20132020","volume":"70","author":"O\u2019Donnell","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.japh.2022.09.018_bib2","author":"Ahmad"},{"issue":"5152","key":"10.1016\/j.japh.2022.09.018_bib4","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.15585\/mmwr.mm675152e1","article-title":"Drug and opioid-involved overdose deaths - United States, 2013\u20132017","volume":"67","author":"Scholl","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"11","key":"10.1016\/j.japh.2022.09.018_bib5","doi-asserted-by":"crossref","first-page":"290","DOI":"10.15585\/mmwr.mm6911a4","article-title":"Drug and opioid-involved overdose deaths\u2014United States, 2017\u20132018","volume":"69","author":"Wilson","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"29","key":"10.1016\/j.japh.2022.09.018_bib6","doi-asserted-by":"crossref","first-page":"940","DOI":"10.15585\/mmwr.mm7129e2","article-title":"Vital signs: drug overdose deaths, by selected sociodemographic and social determinants of health characteristics \u2013 25 States and the District of Columbia, 2019\u20132020","volume":"71","author":"Kariisa","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.japh.2022.09.018_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109398","article-title":"Trends in seizures of powders and pills containing illicit fentanyl in the United States, 2018 through 2021","volume":"234","author":"Palamar","year":"2022","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.japh.2022.09.018_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.addbeh.2017.01.014","article-title":"Prevalence and correlates of fentanyl-contaminated heroin exposure among young adults who use prescription opioids non-medically","volume":"68","author":"Macmadu","year":"2017","journal-title":"Addict Behav"},{"issue":"1","key":"10.1016\/j.japh.2022.09.018_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12954-018-0213-2","article-title":"High willingness to use rapid fentanyl test strips among young adults who use drugs","volume":"15","author":"Krieger","year":"2018","journal-title":"Harm Reduct J"},{"issue":"1","key":"10.1016\/j.japh.2022.09.018_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12954-018-0276-0","article-title":"Perspectives on rapid fentanyl test strips as a harm reduction practice among young adults who use drugs: a qualitative study","volume":"16","author":"Goldman","year":"2019","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.japh.2022.09.018_bib14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.drugpo.2018.09.009","article-title":"Use of rapid fentanyl test strips among young adults who use drugs","volume":"61","author":"Krieger","year":"2018","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.japh.2022.09.018_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.drugpo.2016.11.015","article-title":"Experiences of peer-trainers in a take-home naloxone program: results from a qualitative study","volume":"41","author":"Marshall","year":"2017","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.japh.2022.09.018_bib16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1747-597X-1-28","article-title":"Homeless drug users\u2019 awareness and risk perception of peer \u201ctake home naloxone\u201d use--a qualitative study","volume":"1","author":"Wright","year":"2006","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"1","key":"10.1016\/j.japh.2022.09.018_bib17","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/09687637.2020.1855116","article-title":"Experiences of people who use drugs with naloxone administration: a qualitative study","volume":"29","author":"Rochester","year":"2022","journal-title":"Drugs Educ Prev Policy"},{"issue":"3","key":"10.1016\/j.japh.2022.09.018_bib18","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1037\/prj0000444","article-title":"Models of mental health recovery: an overview of systematic reviews and qualitative meta-syntheses","volume":"44","author":"Dell","year":"2021","journal-title":"Psychiatr Rehabil J"},{"key":"10.1016\/j.japh.2022.09.018_bib19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.drugpo.2018.02.008","article-title":"Effects of naloxone distribution to likely bystanders: results of an agent-based model","volume":"55","author":"Keane","year":"2018","journal-title":"Int J Drug Policy"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319122003193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319122003193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:53:30Z","timestamp":1761544410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319122003193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1544319122003193"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2022.09.018","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A pilot study assessing client understanding and use of fentanyl test strips for harm reduction","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2022.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}